Company intelligence / Profile preview

Jagdale Industries

Bangalore, Karnataka, India

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Jagdale Industries is actively running clinical trials, including Phase 3 studies of Botroclot for diabetic foot ulcers and surgical wounds and has marketed RTD (ready-to-drink) nutritional beverages for hydration, recovery, and chronic conditions. Their "Mulmina Apple" nutraceutical completed a controlled ADHD study in children

Therapeutic areas: EndocrinologyPsychiatryOther
Modalities: Small moleculeProtein (serine proteinases/hemocoagulase formulation)NutraceuticalHealth supplementBeverage
Industry: Biotech

Partnerships

Akums Drugs & Pharmaceuticals (CDMO for RTD beverage manufacturing)

Beyond the preview

Go deeper on Jagdale Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jagdale Industries.

Explore the full profile